Bayer AG (BUE:BAYN) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BUE:BAYN Bayer AG BUE:BAYN
31 GF Score
Price ARS31,100.00
GF Value ARS2,170.33
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Bayer AG FFO?

FFO (Funds from operations) only applies to REITs.

BUE:BAYN
31GF Score
Bayer AG BUE:BAYN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bayer AG (BUE:BAYN) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of ARS31,100.00 is trading 1333% above its estimated GF Value™ of ARS2,170.33. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for BUE:BAYN:

  • FFO:
  • GF Value™: ARS2,170.33 vs. price of ARS31,100.00 (1333% above fair value)
  • GF Score™: 31/100 with 3 warning signs

No single metric tells the full story. See the BUE:BAYN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
31GF Score

Get the complete analysis for BUE:BAYN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS31,100.00
Price
ARS2,170.33
GF Value